{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:33:54Z","timestamp":1793745234883,"version":"4.6.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017804","name":"City of Hope","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omton.2026.201159","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:13:14Z","timestamp":1771517594000},"page":"201159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["CBX6 and CA9 as predictive indicators and therapeutic targets in GBM"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2190-3247","authenticated-orcid":false,"given":"Yujun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yate-Ching","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa Anne","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2026.201159_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.17","article-title":"Glioma","volume":"1","author":"Weller","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.omton.2026.201159_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2019.101896","article-title":"Molecular targeted therapy of glioblastoma","volume":"80","author":"Le Rhun","year":"2019","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.omton.2026.201159_bib3","series-title":"Epidemiology and Outcome of Glioblastoma","author":"Tamimi","year":"2017"},{"key":"10.1016\/j.omton.2026.201159_bib4","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1470-2045(12)70265-6","article-title":"Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial","volume":"13","author":"Malmstrom","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.omton.2026.201159_bib5","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.5603\/RPOR.a2022.0113","article-title":"Survival and quality of life analysis in glioblastoma multiforme with adjuvant chemoradiotherapy: a retrospective study","volume":"27","author":"Mohammed","year":"2022","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"10.1016\/j.omton.2026.201159_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia--a key regulatory factor in tumour growth","volume":"2","author":"Harris","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omton.2026.201159_bib7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fonc.2013.00186","article-title":"Did we get pasteur, warburg, and crabtree on a right note?","volume":"3","author":"Vadlakonda","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2026.201159_bib8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.semcancer.2008.03.011","article-title":"Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression","volume":"18","author":"Fang","year":"2008","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.omton.2026.201159_bib9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrc3298","article-title":"Evolutionary dynamics of carcinogenesis and why targeted therapy does not work","volume":"12","author":"Gillies","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omton.2026.201159_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051176","article-title":"Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy","volume":"14","author":"Park","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omton.2026.201159_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/14756360410001689540","article-title":"Carbonic anhydrases: current state of the art, therapeutic applications and future prospects","volume":"19","author":"Pastorekova","year":"2004","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.omton.2026.201159_bib12","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2026.201159_bib13","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.2174\/138161210793429788","article-title":"Modulation of carbonic anhydrase 9 (CA9) in human brain cancer","volume":"16","author":"Said","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.omton.2026.201159_bib14","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature04871","article-title":"Hypoxia signalling in cancer and approaches to enforce tumour regression","volume":"441","author":"Pouyssegur","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.omton.2026.201159_bib15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.bjc.6600936","article-title":"Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer","volume":"89","author":"Potter","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.omton.2026.201159_bib16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1215\/S1152851705000025","article-title":"Expression of hypoxia-inducible carbonic anhydrases in brain tumors","volume":"7","author":"Proescholdt","year":"2005","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.omton.2026.201159_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/neup.12485","article-title":"Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme","volume":"38","author":"Cetin","year":"2018","journal-title":"Neuropathology"},{"key":"10.1016\/j.omton.2026.201159_bib18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbagrm.2016.12.006","article-title":"Compositional and functional diversity of canonical PRC1 complexes in mammals","volume":"1860","author":"Connelly","year":"2017","journal-title":"Biochim. Biophys. Acta. Gene Regul. Mech."},{"key":"10.1016\/j.omton.2026.201159_bib19","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.tcb.2016.04.009","article-title":"Regulation of Genome Architecture and Function by Polycomb Proteins","volume":"26","author":"Entrevan","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.omton.2026.201159_bib20","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.stem.2014.05.006","article-title":"Chromatin repressive complexes in stem cells, development, and cancer","volume":"14","author":"Laugesen","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omton.2026.201159_bib21","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1158\/1078-0432.CCR-10-2156","article-title":"Aberrations of EZH2 in cancer","volume":"17","author":"Chase","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2026.201159_bib22","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.cell.2014.05.004","article-title":"Variant PRC1 complex-dependent H2A ubiquitylation drives PRC2 recruitment and polycomb domain formation","volume":"157","author":"Blackledge","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.omton.2026.201159_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002774","article-title":"Histone H2A mono-ubiquitination is a crucial step to mediate PRC1-dependent repression of developmental genes to maintain ES cell identity","volume":"8","author":"Endoh","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omton.2026.201159_bib24","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nsmb.2669","article-title":"Transcriptional regulation by Polycomb group proteins","volume":"20","author":"Di Croce","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.omton.2026.201159_bib25","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.tibs.2019.04.005","article-title":"Emerging Roles for Polycomb-Group Proteins in Stem Cells and Cancer","volume":"44","author":"Chan","year":"2019","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.omton.2026.201159_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201800222","article-title":"Cell Fate and Developmental Regulation Dynamics by Polycomb Proteins and 3D Genome Architecture","volume":"41","author":"Loubiere","year":"2019","journal-title":"Bioessays"},{"key":"10.1016\/j.omton.2026.201159_bib27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ncb2701","article-title":"Polycomb Cbx family members mediate the balance between haematopoietic stem cell self-renewal and differentiation","volume":"15","author":"Klauke","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.omton.2026.201159_bib28","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1042\/BST0351401","article-title":"Pc2 and SUMOylation","volume":"35","author":"Wotton","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.omton.2026.201159_bib29","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1074\/jbc.M110.191411","article-title":"Recognition and specificity determinants of the human cbx chromodomains","volume":"286","author":"Kaustov","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2026.201159_bib30","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1631\/jzus.B1400077","article-title":"Epigenetic regulation by polycomb group complexes: focus on roles of CBX proteins","volume":"15","author":"Ma","year":"2014","journal-title":"J. Zhejiang Univ. - Sci. B"},{"key":"10.1016\/j.omton.2026.201159_bib31","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2023.5484","article-title":"Chromobox proteins in cancer: Multifaceted functions and strategies for modulation (Review)","volume":"62","author":"Wang","year":"2023","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.omton.2026.201159_bib32","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.18632\/aging.203912","article-title":"Expression profile and prognostic values of Chromobox family members in human glioblastoma","volume":"14","author":"Li","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.omton.2026.201159_bib33","article-title":"Altered expression of polycomb group genes in glioblastoma multiforme","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omton.2026.201159_bib35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41422-021-00606-6","article-title":"Mechanisms of Polycomb group protein function in cancer","volume":"32","author":"Parreno","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.omton.2026.201159_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.84","article-title":"Roles of the Polycomb group proteins in stem cells and cancer","volume":"2","author":"Richly","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omton.2026.201159_bib37","doi-asserted-by":"crossref","first-page":"18872","DOI":"10.18632\/oncotarget.14770","article-title":"CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma","volume":"8","author":"Zheng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.omton.2026.201159_bib38","first-page":"24","article-title":"The Transcriptional Activity of LAMP3 Gene Involved in Autophagocytosis in Colorectal Cancer LAMP3 Expression in Colorectal Cancer","volume":"5","author":"Bednarczyk","year":"2017","journal-title":"J. Biosci. Med."},{"key":"10.1016\/j.omton.2026.201159_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117493","article-title":"EIF4EBP1 overexpression is associated with poor survival and disease progression in patients with hepatocellular carcinoma","volume":"10","author":"Cha","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.omton.2026.201159_bib40","doi-asserted-by":"crossref","first-page":"24092","DOI":"10.18632\/oncotarget.4483","article-title":"eIF4E binding protein 1 expression is associated with clinical survival outcomes in colorectal cancer","volume":"6","author":"Chao","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.omton.2026.201159_bib41","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1158\/0008-5472.CAN-08-2470","article-title":"Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH","volume":"69","author":"Chiche","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2026.201159_bib42","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/ng.3073","article-title":"An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer","volume":"46","author":"Gatza","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omton.2026.201159_bib43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/bjc.2011.510","article-title":"Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients","volume":"106","author":"Goebel","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.omton.2026.201159_bib44","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1242\/jcs.195552","article-title":"A RhoG-mediated signaling pathway that modulates invadopodia dynamics in breast cancer cells","volume":"130","author":"Goicoechea","year":"2017","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.omton.2026.201159_bib45","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1016\/j.yexcr.2006.09.006","article-title":"Dock4 is regulated by RhoG and promotes Rac-dependent cell migration","volume":"312","author":"Hiramoto","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.omton.2026.201159_bib46","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.2174\/09298673113209990227","article-title":"Histopathological determinants of tumor resistance: a special look to the immunohistochemical expression of carbonic anhydrase IX in human cancers","volume":"21","author":"Ilardi","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.omton.2026.201159_bib47","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3727\/096504001108747792","article-title":"ATF3 gene regulates cell form and migration potential of HT29 colon cancer cells","volume":"12","author":"Ishiguro","year":"2001","journal-title":"Oncol. Res."},{"key":"10.1016\/j.omton.2026.201159_bib48","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1476-4598-11-65","article-title":"The small GTPase RhoG mediates glioblastoma cell invasion","volume":"11","author":"Kwiatkowska","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.omton.2026.201159_bib49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/1759-7714.12421","article-title":"Activating transcription factor 3 promotes malignance of lung cancer cells in vitro","volume":"8","author":"Li","year":"2017","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.omton.2026.201159_bib50","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.3892\/mmr.2017.7349","article-title":"LAMP3 promotes the invasion of osteosarcoma cells via SPP1 signaling","volume":"16","author":"Li","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.omton.2026.201159_bib51","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3892\/ijmm.2015.2173","article-title":"Activating transcription factor 3 is overexpressed in human glioma and its knockdown in glioblastoma cells causes growth inhibition both in vitro and in vivo","volume":"35","author":"Ma","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.omton.2026.201159_bib52","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1158\/1078-0432.CCR-13-0526","article-title":"Hypoxic activation of the PERK\/eIF2alpha arm of the unfolded protein response promotes metastasis through induction of LAMP3","volume":"19","author":"Mujcic","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2026.201159_bib53","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1038\/onc.2015.515","article-title":"Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis","volume":"35","author":"Musa","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2026.201159_bib54","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1530\/ERC-13-0183","article-title":"LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagy","volume":"21","author":"Nagelkerke","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.omton.2026.201159_bib55","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/15384101.2016.1151581","article-title":"4E-BP1, a multifactor regulated multifunctional protein","volume":"15","author":"Qin","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.omton.2026.201159_bib56","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1158\/0008-5472.CAN-03-2224","article-title":"Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion","volume":"64","author":"Robertson","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2026.201159_bib57","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1242\/jcs.072207","article-title":"Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion","volume":"124","author":"Shin","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.omton.2026.201159_bib58","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.febslet.2008.04.039","article-title":"Rho GTPases in cancer cell biology","volume":"582","author":"Vega","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omton.2026.201159_bib59","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1042\/BST20160478","article-title":"CD81 as a tumor target","volume":"45","author":"Vences-Catalan","year":"2017","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.omton.2026.201159_bib60","doi-asserted-by":"crossref","first-page":"8329","DOI":"10.1007\/s13277-014-2044-4","article-title":"Activating transcription factor 3 promotes colon cancer metastasis","volume":"35","author":"Wu","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.omton.2026.201159_bib61","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.12659\/MSM.911612","article-title":"Increased Expression of CD81 in Breast Cancer Tissue is Associated with Reduced Patient Prognosis and Increased Cell Migration and Proliferation in MDA-MB-231 and MDA-MB-435S Human Breast Cancer Cell Lines In Vitro","volume":"24","author":"Zhang","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.omton.2026.201159_bib62","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/COC.0000000000000691","article-title":"A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors","volume":"43","author":"McDonald","year":"2020","journal-title":"Am. J. Clin. Oncol."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926000354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926000354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T08:18:12Z","timestamp":1783325892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329926000354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2950329926000354"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2026.201159","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CBX6 and CA9 as predictive indicators and therapeutic targets in GBM","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2026.201159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201159"}}